TABLE 3

Semen Analysis Parameters After Discontinuation of Therapy for Gender Dysphoria

PatientGender-Affirming TherapySemen Parameters
Leuprolide Acetate, mg per 28 dSpironolactone, mg per dEstradiol, μg per dAge of Initiation, yDuration of Therapy, moDuration of Therapy Discontinuation, moVolume, mLDensity (per mL), SpermMotility, %Morphology, %No. Sperm Cryopreserved
115N/AN/A17.56311216.6N/A12
5273 million 569146 million
2N/A10075182622.50N/AN/A0
31.50N/AN/A0
41.70N/AN/A0
  • N/A, not applicable.